Protein S deficiency: A clinical perspective

Haemophilia

Volumn 14, Issue 6, 2008, Pages 1222-1228

  Ten Kate, M K ^a   Van Der Meer, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

PROS1; Protein S; Protein S deficiency; Review; Thrombosis; Venous thromboembolism

Indexed keywords

APC PROTEIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN S; TISSUE FACTOR PATHWAY INHIBITOR; WARFARIN;

ANTICOAGULATION; FETUS WASTAGE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN S DEFICIENCY; REVIEW; RISK FACTOR; SKIN NECROSIS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGE OF ONSET; ANTICOAGULANTS; BLOOD COAGULATION TESTS; BLOOD PROTEINS; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FALSE POSITIVE REACTIONS; FEMALE; HETEROZYGOTE; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTERS; PROTEIN S; PROTEIN S DEFICIENCY; RECURRENCE; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 55949086628     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01775.x     Document Type: Review

References (33)

1. Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977; 16: 698-706.
2. Walker FJ. Regulation of activated protein C by a new protein: A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
3. Dahlback B. The tale of protein S and C4b-binding protein, a story of affection. Thromb Haemost 2007; 98: 90-6.
4. Dahlback B. Inhibition of protein C cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-7.
5. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-300.
6. Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of Protein S antigen levels in 3788 healthy volunteers: Influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-41.
7. Beauchamp NJ, Dykes AC, Parikh N, Campbell Tait R, Daly ME. The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population. Br J Haematol 2004; 125: 647-54.
8. Lane DA, Mannucci PM, Bauer KA et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-62.
9. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-31.
10. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: Importance of protein S K196E mutation. Int J Hematol 2006; 83: 217-23.
11. Kinoshita S, Iida H, Inoue S et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005; 38: 908-15.
12. Chen TY, Su WC, Tsao CJ. Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Ann Hematol 2003; 82: 114-7.
13. Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: Different roles for protein S and the protein S-C4b binding protein complex. Blood 2004; 103: 1192-201.
14. De Frutos PG, Fuentes-Prior P, Hurtado B, Sala N. Molecular basis of protein S deficiency. Thromb Haemost 2007; 98: 543-56.
15. Maurissen LF, Thomassen MC, Nicolaes GA et al. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 2008; 111: 3034-41.
16. Sakata Y, Loskutoff DJ, Gladson CL, Hekman CM, Griffin JH. Mechanism of protein C-dependent clot lysis: Role of plasminogen activator inhibitor. Blood 1986; 68: 1218-23.
17. Mosnier LO, Meijers JC, Bouma BN. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis. Thromb Haemost 2001; 86: 1040-6.
18. Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 2006; 103: 3106-11.
19. Tatewaki H, Tsuda H, Kanaji T, Yokoyama K, Hamasaki N. Characterization of the human protein S gene promoter: A possible role of transcription factors Sp1 and HNF3 in liver. Thromb Haemost 2003; 90: 1029-39.
20. De Wolf CJ, Cupers RM, Bertina RM, Vos HL. The constitutive expression of anticoagulant protein S is regulated through multiple binding sites for Sp1 and Sp3 transcription factors in the protein S gene promoter. J Biol Chem 2006; 281: 17635-43.
21. Bertina RM, Ploos van Amstel HK, van Wijngaarden A et al. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-48.
22. Giri TK, Yamazaki T, Sala N, Dahlbäck B, de Frutos PG. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: A possible mechanism of synergism between thrombophilic risk factors. Blood 2000; 96: 523-31.
23. Johansson AM, Hillarp A, Säll T, Zöller B, Dahlbäck B, Halldén C. Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency. Thromb Haemost 2005; 94: 951-7.
24. Espinosa-Parrilla Y, Morell M, Souto JC et al. Protein S gene analysis reveals the presence of a cosegregating mutation in most pedigrees with type I but not type III PS deficiency. Hum Mutat 1999; 14: 30-9.
25. Ten Kate MK, Platteel M, Mulder R et al. PROS1 analysis in 87 pedigrees with hereditary protein S deficiency demonstrates striking genotype-phenotype associations. Hum Mutat 2008 (in press). doi: 10.1002/ humu.20687
26. Brouwer JL, Veeger NJ, van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III: Results from a family cohort study to assess the clinical impact of a laboratory test-based classification. Br J Haematol 2005; 128: 703-10.
27. Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The pathogenesis of venous thromboembolism: Evidence for multiple interrelated causes. Ann Intern Med 2006; 145: 807-15.
28. Van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Arch Intern Med 2007; 167: 282-9.
29. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv 1999; 54: 265-71.
30. Folkeringa N, Brouwer JL, Korteweg FJ et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol 2007; 136: 656-61.
31. Biguzzi E, Razzari C, Lane DA et al. Molecular diversity and thrombotic risk in protein S deficiency: The PROSIT study. Hum Mutat 2005; 25: 259-69.
32. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med 2002; 126: 1349-66.
33. O'Brien AE, Tate GM, Shiach C. Evaluation of protein C and protein S levels during oral anticoagulant therapy. Clin Lab Haematol 1998; 20: 245-52.